Statins in Candidemia: clinical outcomes from a matched cohort study

BACKGROUND: HMG CoA reductase inhibitors (statins) in patients with bacteremic sepsis have shown significant survival benefits in several studies. There is no data on the effect of statins in candidemic patients, however in-vitro models suggest that statins interfere with ergesterol formation in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Forrest, Graeme N, Kopack, Angela M, Perencevich, Eli N
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894022/
https://www.ncbi.nlm.nih.gov/pubmed/20525374
http://dx.doi.org/10.1186/1471-2334-10-152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894022/
https://www.ncbi.nlm.nih.gov/pubmed/20525374
http://dx.doi.org/10.1186/1471-2334-10-152

Ejemplares similares